Nykode Therapeutics AS (OSL:NYKD)
kr 1.899 +0.049 (+2.65%) Market Cap: 620.11 Mil Enterprise Value: -420.04 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 41/100